FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称EGANELISIB
异名/同义词(S)-2-AMINO-N-(1-(8-((1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-1,2- DIHYDROISOQUINOLIN-3-YL)ETHYL)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE
2-AMINO-N-((1S)-1-(8-(2-(1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL- 1,2-DIHYDROISOQUINOLIN-3-YL)ETHYL)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE
EGANELISIB
EGANELISIB [INN]
EGANELISIB [USAN]
EGANELISIB [WHO-DD]
IPI-549
PI3K-GAMMA INHIBITOR IPI-549
PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE, 2-AMINO-N-((1S)-1-(1,2-DIHYDRO-8-(2-(1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-3-ISOQUINOLINYL)ETHYL)-
CAS登记号1693758-51-8
物质唯一标识(Unique Ingredient Identifier)FOF5155FMZ
分子式C30H24N8O2
国际化合物标识(International Chemical Identifier,InChI)XUMALORDVCFWKV-IBGZPJMESA-N
SMILESc12ncccn1nc(c2C(=O)N[C@@H](C)c3n(c(c4c(cccc4c3)C#Cc5cnn(c5)C)=O)-c6ccccc6)N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System